Titanium dioxide nanoparticles enhanced Nrf2 expression in liver cancer cells along with its associated target genes NQO1, HO-1, and GCLC, while Nrf2 loss in Nrf2(−/−) cells significantly increased susceptibility to DNA damage [119]. The gene discussed is NFE2L2; the disease is liver cancer.